{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:43:32Z","timestamp":1776372212004,"version":"3.51.2"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations to the gene encoding superoxide dismutase-1 (SOD1) were the first genetic elements discovered that cause motor neuron disease (MND). These mutations result in compromised SOD1 dimer stability, with one of the severest and most common mutations Ala4Val (A4V) displaying a propensity to monomerise and aggregate leading to neuronal death. We show that the clinically used ebselen and related\u00a0analogues promote thermal stability of A4V SOD1 when binding to Cys111 only. We have developed a A4V SOD1 differential scanning fluorescence-based assay on a C6S mutation background that is effective in assessing suitability of compounds. Crystallographic data show that the selenium atom of these compounds binds covalently to A4V SOD1 at Cys111 at the dimer interface, resulting in stabilisation. This together with chemical amenability for hit expansion of ebselen and its on-target SOD1 pharmacological chaperone activity holds remarkable promise for structure-based therapeutics for MND using ebselen as a template.<\/jats:p>","DOI":"10.1038\/s42003-020-0826-3","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T11:06:26Z","timestamp":1583406386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Ebselen as template for stabilization of A4V mutant dimer for motor neuron disease therapy"],"prefix":"10.1038","volume":"3","author":[{"given":"Varunya","family":"Chantadul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3756-9634","authenticated-orcid":false,"given":"Gareth S. A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangsa","family":"Amporndanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munazza","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2779-9946","authenticated-orcid":false,"given":"Svetlana V.","family":"Antonyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Washbourn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Pye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2854-4718","authenticated-orcid":false,"given":"S. Samar","family":"Hasnain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"826_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown, R. H. & Al-Chalabi, A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 377, 162\u2013172 (2017).","journal-title":"N. Engl. J. Med."},{"key":"826_CR2","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrn1971","volume":"7","author":"P Pasinelli","year":"2006","unstructured":"Pasinelli, P. & Brown, R. H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7, 710\u2013723 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"826_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen, D. R. et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59\u201362 (1993).","journal-title":"Nature"},{"key":"826_CR4","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1212\/01.wnl.0000343509.76828.2a","volume":"72","author":"M Saeed","year":"2009","unstructured":"Saeed, M. et al. Age and founder effect of SOD1 A4V mutation causing ALS. Neurology 72, 1634\u20131639 (2009).","journal-title":"Neurology"},{"key":"826_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1146\/annurev.bi.44.070175.001051","volume":"44","author":"I Fridovich","year":"1975","unstructured":"Fridovich, I. Superoxide dismutases. Annu. Rev. Biochem. 44, 147\u2013159 (1975).","journal-title":"Annu. Rev. Biochem."},{"key":"826_CR6","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1126\/science.281.5384.1851","volume":"281","author":"LI Bruijn","year":"1998","unstructured":"Bruijn, L. I. et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281, 1851\u20131854 (1998).","journal-title":"Science"},{"key":"826_CR7","doi-asserted-by":"publisher","first-page":"15499","DOI":"10.1074\/jbc.M313295200","volume":"279","author":"R Rakhit","year":"2004","unstructured":"Rakhit, R. et al. Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J. Biol. Chem. 279, 15499\u201315504 (2004).","journal-title":"J. Biol. Chem."},{"key":"826_CR8","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1021\/bi030246r","volume":"43","author":"SS Ray","year":"2004","unstructured":"Ray, S. S. et al. An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis. Biochemistry 43, 4899\u20134905 (2004).","journal-title":"Biochemistry"},{"key":"826_CR9","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1073\/pnas.0408277102","volume":"102","author":"SS Ray","year":"2005","unstructured":"Ray, S. S., Nowak, R. J., Brown, R. H. Jr. & Lansbury, P. T. Jr. Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation. Proc. Natl Acad. Sci. USA 102, 3639\u20133644 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"826_CR10","doi-asserted-by":"publisher","first-page":"15094","DOI":"10.1073\/pnas.0406650101","volume":"101","author":"SD Khare","year":"2004","unstructured":"Khare, S. D., Caplow, M. & Dokholyan, N. V. The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 101, 15094\u201315099 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"826_CR11","doi-asserted-by":"publisher","first-page":"21394","DOI":"10.1073\/pnas.1015463107","volume":"107","author":"JR Auclair","year":"2010","unstructured":"Auclair, J. R., Boggio, K. J., Petsko, G. A., Ringe, D. & Agar, J. N. Strategies for stabilizing superoxide dismutase (SOD1), the protein destabilized in the most common form of familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 107, 21394\u201321399 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"826_CR12","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1021\/ja211591n","volume":"134","author":"L Banci","year":"2012","unstructured":"Banci, L. et al. Interaction of cisplatin with human superoxide dismutase. J. Am. Chem. Soc. 134, 7009\u20137014 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"826_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04114-x","volume":"9","author":"MJ Capper","year":"2018","unstructured":"Capper, M. J. et al. The cysteine-reactive small molecule ebselen facilitates effective SOD1 maturation. Nat. Commun. 9, 1693 (2018).","journal-title":"Nat. Commun."},{"key":"826_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep27691","volume":"6","author":"GS Wright","year":"2016","unstructured":"Wright, G. S., Antonyuk, S. V. & Hasnain, S. S. A faulty interaction between SOD1 and hCCS in neurodegenerative disease. Sci. Rep. 6, 27691 (2016).","journal-title":"Sci. Rep."},{"key":"826_CR15","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.1007\/s11033-014-3417-x","volume":"41","author":"GK Azad","year":"2014","unstructured":"Azad, G. K. & Tomar, R. S. Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways. Mol. Biol. Rep. 41, 4865\u20134879 (2014).","journal-title":"Mol. Biol. Rep."},{"key":"826_CR16","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/sj.bjp.0701426","volume":"122","author":"T Takasago","year":"1997","unstructured":"Takasago, T., Peters, E. E., Graham, D. I., Masayasu, H. & Macrae, I. M. Neuroprotective efficacy of ebselen, an anti-oxidant with anti-inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion. Br. J. Pharmacol. 122, 1251\u20131256 (1997).","journal-title":"Br. J. Pharmacol."},{"key":"826_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11064-005-2615-2","volume":"30","author":"M Kalayci","year":"2005","unstructured":"Kalayci, M. et al. Neuroprotective effects of ebselen on experimental spinal cord injury in rats. Neurochem. Res. 30, 403\u2013410 (2005).","journal-title":"Neurochem. Res."},{"key":"826_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jpsychires.2018.11.021","volume":"109","author":"F Martini","year":"2019","unstructured":"Martini, F. et al. A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer\u2019s disease. J. Psychiatr. Res 109, 107\u2013117 (2019).","journal-title":"J. Psychiatr. Res"},{"key":"826_CR19","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/brain\/awl118","volume":"129","author":"CA Wood-Allum","year":"2006","unstructured":"Wood-Allum, C. A. et al. Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen. Brain 129, 1693\u20131709 (2006).","journal-title":"Brain"},{"key":"826_CR20","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1073\/pnas.0305143101","volume":"101","author":"MA Hough","year":"2004","unstructured":"Hough, M. A. et al. Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. Proc. Natl Acad. Sci. USA 101, 5976\u20135981 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"826_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.abb.2009.09.020","volume":"492","author":"A Galaleldeen","year":"2009","unstructured":"Galaleldeen, A. et al. Structural and biophysical properties of metal-free pathogenic SOD1 mutants A4V and G93A. Arch. Biochem. Biophys. 492, 40\u201347 (2009).","journal-title":"Arch. Biochem. Biophys."},{"key":"826_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0022-2836(02)01090-2","volume":"324","author":"RMF Cardoso","year":"2002","unstructured":"Cardoso, R. M. F. et al. Insights into Lou Gehrig\u2019s disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase. J. Mol. Biol. 324, 247\u2013256 (2002).","journal-title":"J. Mol. Biol."},{"key":"826_CR23","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1073\/pnas.0511266103","volume":"103","author":"SD Khare","year":"2006","unstructured":"Khare, S. D. & Dokholyan, N. V. Common dynamical signatures of familial amyotrophic lateral sclerosis-associated structurally diverse Cu, Zn superoxide dismutase mutants. Proc. Natl Acad. Sci. USA 103, 3147\u20133152 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"826_CR24","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.bpj.2009.06.043","volume":"97","author":"T Schmidlin","year":"2009","unstructured":"Schmidlin, T., Kennedy, B. K. & Daggett, V. Structural changes to monomeric CuZn superoxide dismutase caused by the familial amyotrophic lateral sclerosis-associated mutation A4V. Biophys. J. 97, 1709\u20131718 (2009).","journal-title":"Biophys. J."},{"key":"826_CR25","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0022-2836(03)00355-3","volume":"328","author":"RW Strange","year":"2003","unstructured":"Strange, R. W. et al. The structure of Holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis. J. Mol. Biol. 328, 877\u2013891 (2003).","journal-title":"J. Mol. Biol."},{"key":"826_CR26","doi-asserted-by":"publisher","first-page":"29771","DOI":"10.1074\/jbc.M504039200","volume":"280","author":"A Tiwari","year":"2005","unstructured":"Tiwari, A., Xu, Z. & Hayward, L. J. Aberrantly increased hydrophobicity shared by mutants of Cu,Zn-superoxide dismutase in familial amyotrophic lateral sclerosis. J. Biol. Chem. 280, 29771\u201329779 (2005).","journal-title":"J. Biol. Chem."},{"key":"826_CR27","doi-asserted-by":"publisher","first-page":"13940","DOI":"10.1074\/jbc.M809687200","volume":"284","author":"KC Wilcox","year":"2009","unstructured":"Wilcox, K. C. et al. Modifications of superoxide dismutase (SOD1) in human erythrocytes: a possible role in amyotrophic lateral sclerosis. J. Biol. Chem. 284, 13940\u201313947 (2009).","journal-title":"J. Biol. Chem."},{"key":"826_CR28","doi-asserted-by":"publisher","first-page":"17197","DOI":"10.1074\/jbc.M115.708230","volume":"291","author":"C Alvarez-Zaldiernas","year":"2016","unstructured":"Alvarez-Zaldiernas, C. et al. Cellular redox systems impact the aggregation of Cu,Zn superoxide dismutase linked to familial amyotrophic lateral sclerosis. J. Biol. Chem. 291, 17197\u201317208 (2016).","journal-title":"J. Biol. Chem."},{"key":"826_CR29","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1074\/jbc.M705657200","volume":"283","author":"M Cozzolino","year":"2008","unstructured":"Cozzolino, M. et al. Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis. J. Biol. Chem. 283, 866\u2013874 (2008).","journal-title":"J. Biol. Chem."},{"key":"826_CR30","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1074\/jbc.M112.414235","volume":"288","author":"K Toichi","year":"2013","unstructured":"Toichi, K., Yamanaka, K. & Furukawa, Y. Disulfide scrambling describes the oligomer formation of superoxide dismutase (SOD1) proteins in the familial form of amyotrophic lateral sclerosis. J. Biol. Chem. 288, 4970\u20134980 (2013).","journal-title":"J. Biol. Chem."},{"key":"826_CR31","doi-asserted-by":"publisher","unstructured":"Janiak, C. A critical account on \u03c0\u2013\u03c0 stacking in metal complexes with aromatic nitrogen-containing ligands.\u200a J. Chem. Soc. Dalton Trans. 3885\u20133896, https:\/\/doi.org\/10.1039\/b003010o (2000).","DOI":"10.1039\/b003010o"},{"key":"826_CR32","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1039\/C7MD00381A","volume":"8","author":"R Ferreira de Freitas","year":"2017","unstructured":"Ferreira de Freitas, R. & Schapira, M. A systematic analysis of atomic protein-ligand interactions in the PDB. Medchemcomm 8, 1970\u20131981 (2017).","journal-title":"Medchemcomm"},{"key":"826_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0022-2836(91)90725-L","volume":"218","author":"L Serrano","year":"1991","unstructured":"Serrano, L., Bycroft, M. & Fersht, A. R. Aromatic-aromatic interactions and protein stability: Investigation by double-mutant cycles. J. Mol. Biol. 218, 465\u2013475 (1991).","journal-title":"J. Mol. Biol."},{"key":"826_CR34","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/pro.2814","volume":"24","author":"K Madhusudan Makwana","year":"2015","unstructured":"Madhusudan Makwana, K. & Mahalakshmi, R. Implications of aromatic-aromatic interactions: from protein structures to peptide models. Protein Sci. 24, 1920\u20131933 (2015).","journal-title":"Protein Sci."},{"key":"826_CR35","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/nprot.2007.321","volume":"2","author":"FH Niesen","year":"2007","unstructured":"Niesen, F. H., Berglund, H. & Vedadi, M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat. Protoc. 2, 2212 (2007).","journal-title":"Nat. Protoc."},{"key":"826_CR36","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.drudis.2009.07.014","volume":"14","author":"TJ Ritchie","year":"2009","unstructured":"Ritchie, T. J. & Macdonald, S. J. The impact of aromatic ring count on compound developability\u2013are too many aromatic rings a liability in drug design? Drug Disco. Today 14, 1011\u20131020 (2009).","journal-title":"Drug Disco. Today"},{"key":"826_CR37","unstructured":"Patrick, G. L. An Introduction to Medicinal Chemistry. 6th edn. (Oxford University Press, 2013)."},{"key":"826_CR38","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1073\/pnas.0913021108","volume":"108","author":"KA Vassall","year":"2011","unstructured":"Vassall, K. A. et al. Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS. Proc. Natl Acad. Sci. USA 108, 2210\u20132215 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"826_CR39","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1021\/acschembio.6b00031","volume":"11","author":"HJ Reich","year":"2016","unstructured":"Reich, H. J. & Hondal, R. J. Why nature chose selenium. ACS Chem. Biol. 11, 821\u2013841 (2016).","journal-title":"ACS Chem. Biol."},{"key":"826_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2750","volume":"4","author":"GS Wright","year":"2013","unstructured":"Wright, G. S., Antonyuk, S. V., Kershaw, N. M., Strange, R. W. & Samar Hasnain, S. Ligand binding and aggregation of pathogenic SOD1. Nat. Commun. 4, 1758 (2013).","journal-title":"Nat. Commun."},{"key":"826_CR41","unstructured":"Bartels, K. S. & Klein, C. The AUTOMAR Manual v1.5, https:\/\/marxperts.com\/pdf\/automar-manual.pdf (2005)."},{"key":"826_CR42","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. D. Biol. Crystallogr. 69, 1204\u20131214 (2013).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"826_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1107\/S2059798317017235","volume":"74","author":"G Winter","year":"2018","unstructured":"Winter, G. et al. DIALS: implementation and evaluation of a new integration package. Acta Crystallogr. D. Struct. Biol. 74, 85\u201397 (2018).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"826_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1107\/S0907444910048675","volume":"67","author":"TGG Battye","year":"2011","unstructured":"Battye, T. G. G., Kontogiannis, L., Johnson, O., Powell, H. R. & Leslie, A. G. W. iMOSFLM: a new graphical interface for diffraction-image processing withMOSFLM. Acta Crystallogr. Sect. D. Biol. Crystallogr. 67, 271\u2013281 (2011).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"826_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1107\/S0907444909042589","volume":"66","author":"A Vagin","year":"2010","unstructured":"Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr. D. Biol. Crystallogr. 66, 22\u201325 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"826_CR46","doi-asserted-by":"crossref","unstructured":"Collaborative, Computational Project. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol Crystallogr. 50, 760\u2013763 (1994).","DOI":"10.1107\/S0907444994003112"},{"key":"826_CR47","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1107\/S0907444996012255","volume":"53","author":"GN Murshudov","year":"1997","unstructured":"Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D. Biol. Crystallogr. 53, 240\u2013255 (1997).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"826_CR48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D. Biol. Crystallogr. 67, 355\u2013367 (2011).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"826_CR49","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"826_CR50","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1107\/S090744491200251X","volume":"68","author":"AA Lebedev","year":"2012","unstructured":"Lebedev, A. A. et al. JLigand: a graphical tool for the CCP4 template-restraint library. Acta Crystallogr. D. Biol. Crystallogr. 68, 431\u2013440 (2012).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"826_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. Sect. D. Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"826_CR52","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/cn100008c","volume":"1","author":"TT Wager","year":"2010","unstructured":"Wager, T. T., Hou, X., Verhoest, P. R. & Villalobos, A. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties. ACS Chem. Neurosci. 1, 435\u2013449 (2010).","journal-title":"ACS Chem. Neurosci."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-0826-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-0826-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-0826-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T01:42:47Z","timestamp":1670377367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-0826-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1038\/s42003-020-0826-3","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"assertion":[{"value":"21 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}